Vm24, a Natural Immunosuppressive Peptide, Potently and Selectively Blocks Kv1.3 Potassium Channels of Human T Cells

Blockade of Kv1.3 K+ channels in T cells is a promising therapeutic approach for the treatment of autoimmune diseases such as multiple sclerosis and type 1 diabetes mellitus. Vm24 (α-KTx 23.1) is a novel 36-residue Kv1.3-specific peptide isolated from the venom of the scorpion Vaejovis mexicanus smithi. Vm24 inhibits Kv1.3 channels of human lymphocytes with high affinity (Kd = 2.9 pM) and exhibits >1500-fold selectivity over other ion channels assayed. It inhibits the proliferation and Ca2+ signaling of human T cells in vitro and reduces delayed-type hypersensitivity reactions in rats in vivo. Our results indicate that Vm24 has exceptional pharmacological properties that make it an excellent candidate for treatment of certain autoimmune diseases.

[1]  R. C. Rodríguez de la Vega,et al.  Structure, function, and chemical synthesis of Vaejovis mexicanus peptide 24: a novel potent blocker of Kv1.3 potassium channels of human T lymphocytes. , 2012, Biochemistry.

[2]  K. Chandy,et al.  The functional network of ion channels in T lymphocytes , 2009, Immunological reviews.

[3]  Brian J. Smith,et al.  Engineering a Stable and Selective Peptide Blocker of the Kv1.3 Channel in T Lymphocytes , 2009, Molecular Pharmacology.

[4]  R. C. Rodríguez de la Vega,et al.  A selective blocker of Kv1.2 and Kv1.3 potassium channels from the venom of the scorpion Centruroides suffusus suffusus. , 2008, Biochemical pharmacology.

[5]  Hui Liu,et al.  Structural Basis of a Potent Peptide Inhibitor Designed for Kv1.3 Channel, a Therapeutic Target of Autoimmune Disease* , 2008, Journal of Biological Chemistry.

[6]  H. Wiendl,et al.  TWIK-related Acid-sensitive K+ Channel 1 (TASK1) and TASK3 Critically Influence T Lymphocyte Effector Functions* , 2008, Journal of Biological Chemistry.

[7]  Daniel J. Estes,et al.  High-throughput profiling of ion channel activity in primary human lymphocytes. , 2008, Analytical chemistry.

[8]  P. Calabresi,et al.  Characterization of the Functional Properties of the Voltage-Gated Potassium Channel Kv1.3 in Human CD4+ T Lymphocytes1 , 2007, The Journal of Immunology.

[9]  K. Chandy,et al.  Induction and Monitoring of Adoptive Delayed-Type Hypersensitivity in Rats , 2007, Journal of visualized experiments : JoVE.

[10]  K. Chandy,et al.  Induction and monitoring of active delayed type hypersensitivity (DTH) in rats. , 2007, Journal of visualized experiments : JoVE.

[11]  L. Possani,et al.  Proteomic analysis of the venom from the scorpion Tityus stigmurus: biochemical and physiological comparison with other Tityus species. , 2007, Comparative biochemistry and physiology. Toxicology & pharmacology : CBP.

[12]  S. Korn,et al.  Voltage-Gated Potassium Channels , 2007 .

[13]  S. Griffey,et al.  Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases , 2006, Proceedings of the National Academy of Sciences.

[14]  G. Pedraza-Alva,et al.  TCR-Dependent Cell Response Is Modulated by the Timing of CD43 Engagement1 , 2006, The Journal of Immunology.

[15]  R. C. Rodríguez de la Vega,et al.  K+ channel blockers: novel tools to inhibit T cell activation leading to specific immunosuppression. , 2006, Current pharmaceutical design.

[16]  L. Possani,et al.  Anuroctoxin, a New Scorpion Toxin of the α-KTx 6 Subfamily, Is Highly Selective for Kv1.3 over IKCa1 Ion Channels of Human T Lymphocytes , 2005, Molecular Pharmacology.

[17]  S. Grissmer,et al.  K+ channel types targeted by synthetic OSK1, a toxin from Orthochirus scrobiculosus scorpion venom. , 2005, The Biochemical journal.

[18]  K. Giangiacomo,et al.  Molecular basis of a-KTx specificity , 2004 .

[19]  Z. Varga,et al.  Ion channels and lymphocyte activation. , 2004, Immunology letters.

[20]  K. Giangiacomo,et al.  Molecular basis of alpha-KTx specificity. , 2004, Toxicon : official journal of the International Society on Toxinology.

[21]  O. McManus,et al.  Substitution of a single residue in Stichodactyla helianthus peptide, ShK-Dap22, reveals a novel pharmacological profile. , 2003, Biochemistry.

[22]  P. Calabresi,et al.  The voltage-gated Kv1.3 K(+) channel in effector memory T cells as new target for MS. , 2003, The Journal of clinical investigation.

[23]  T. Hoshi,et al.  Stimulatory action of internal protons on Slo1 BK channels. , 2003, Biophysical journal.

[24]  James J. Campbell,et al.  CCR4 versus CCR10 in human cutaneous TH lymphocyte trafficking. , 2003, Blood.

[25]  K. Chandy,et al.  Delineation of the Clotrimazole/TRAM-34 Binding Site on the Intermediate Conductance Calcium-activated Potassium Channel, IKCa1* , 2001, The Journal of Biological Chemistry.

[26]  S. James.  Measurement of Proliferative Responses of Cultured Lymphocytes , 1994, Current protocols in immunology.

[27]  E. Horjales,et al.  Effects of Toxins Pi2 and Pi3 on Human T Lymphocyte Kv1.3 Channels: The Role of Glu7 and Lys24 , 2001, The Journal of Membrane Biology.

[28]  Richard S Lewis,et al.  Calcium signaling mechanisms in T lymphocytes. , 2001, Annual review of immunology.

[29]  Mark J. Miller,et al.  Up-regulation of the IKCa1 Potassium Channel during T-cell Activation , 2000, The Journal of Biological Chemistry.

[30]  M. L. García,et al.  Electrostatic mutations in iberiotoxin as a unique tool for probing the electrostatic structure of the maxi-K channel outer vestibule. , 1999, Biochemistry.

[31]  E. Christian,et al.  ShK-Dap22, a Potent Kv1.3-specific Immunosuppressive Polypeptide* , 1998, The Journal of Biological Chemistry.

[32]  A. Koschak,et al.  Subunit Composition of Brain Voltage-gated Potassium Channels Determined by Hongotoxin-1, a Novel Peptide Derived fromCentruroides limbatus Venom* , 1998, The Journal of Biological Chemistry.

[33]  O. Pongs,et al.  A four-disulphide-bridged toxin, with high affinity towards voltage-gated K+ channels, isolated from Heterometrus spinnifer (Scorpionidae) venom. , 1997, The Biochemical journal.

[34]  C. Schwarzer,et al.  Complex Subunit Assembly of Neuronal Voltage-gated K+Channels , 1997, The Journal of Biological Chemistry.

[35]  C. Roumestand,et al.  On the Convergent Evolution of Animal Toxins , 1997, The Journal of Biological Chemistry.

[36]  G A Gutman,et al.  Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines. , 1994, Molecular pharmacology.

[37]  S. Grissmer,et al.  Calcium-activated potassium channels in resting and activated human T lymphocytes. Expression levels, calcium dependence, ion selectivity, and pharmacology , 1993, The Journal of general physiology.

[38]  C. Miller,et al.  Mechanism of charybdotoxin block of a voltage-gated K+ channel. , 1993, Biophysical journal.

[39]  M. Garcia-Calvo,et al.  Purification, characterization, and biosynthesis of margatoxin, a component of Centruroides margaritatus venom that selectively inhibits voltage-dependent potassium channels. , 1993, The Journal of biological chemistry.

[40]  O. McManus,et al.  Synthetic charybdotoxin-iberiotoxin chimeric peptides define toxin binding sites on calcium-activated and voltage-dependent potassium channels. , 1993, Biochemistry.

[41]  N. Sigal,et al.  Voltage-gated potassium channels regulate calcium-dependent pathways involved in human T lymphocyte activation , 1993, The Journal of experimental medicine.

[42]  J. Reuben,et al.  Selective blockers of voltage-gated K+ channels depolarize human T lymphocytes: mechanism of the antiproliferative effect of charybdotoxin. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[43]  C. Park,et al.  Mapping function to structure in a channel-blocking peptide: electrostatic mutants of charybdotoxin. , 1992, Biochemistry.

[44]  Chul-Seung Park,et al.  Interaction of charybdotoxin with permeant ions inside the pore of a K+ channel , 1992, Neuron.

[45]  C. Deutsch,et al.  K channels in T lymphocytes: a patch clamp study using monoclonal antibody adhesion , 1984, Nature.